Strong Demand for Lung Intelligence Accelerates VIDA’s Growth
CORALVILLE, Iowa, May 4, 2022 /PRNewswire/ -- VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, announced it has secured financing as it scales up to support strong demand for its VIDA Intelligence Portal, an AI-powered solution that...
StationMD Achieves HITRUST Risk-based, 2-year Certification
Maplewood, N.J., May 18, 2022 – StationMD, a leading provider of telemedicine for individuals with intellectual and developmental disabilities (I/DD) today announced that its proprietary telemedicine management system, StationConnect, has earned Certified status for...
Strong Demand for Lung Intelligence Accelerates VIDA’s Growth
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, announced it has secured financing as it scales up to support strong demand for its VIDA Intelligence Portal, an AI-powered solution that supports clinical trial decentralization and...